APLN and neoplasm: To test the impact of APLN derived from the TME, APLN-KO mice were used in various orthotopic GBM models (using syngeneic tumor cells or xenografts) [42,44]; consistently, APLN was found to be upregulated in the tumor neovasculature as compared to tumor-free control areas (Figure 1A).